BF Biosciences inks deal with Lucky Core

By MG News | Category Equity | September 04, 2024 at 10:30 AM GMT+05:00

0:00

September 04, 2024 (MLN): BF Biosciences Limited (BFBL)has entered into a contract manufacturing and supply agreement with Lucky Core Industries Limited (LCI) for the products "Esopase IV 40 mg" & "Etipro IV 40 mg", the company's filing on PSX revealed.

BFBL is a subsidiary of Ferozsons Laboratories Limited (PSX: FEROZ).

In August, BF Biosciences successfully launched human insulin under the brand name "Ferulin".

BF Biosciences was established exclusively for the manufacture of biologicals and it is the first and only company in Pakistan currently to have a biotech manufacturing facility.

Copyright Mettis Link News

Related News

FCCL denies interest in ACPL, issues clarification on media speculation

PSX Closing bell: Drop Zone

SHFA to approve nearly 106m share acquisition in SMCI at EOGM

Name	Price/Vol	%Chg/NChg
KSE100	121,641.00 407.56M	-0.13% -157.87
ALLSHR	75,951.71 854.04M	-0.10% -76.82
KSE30	36,827.89 67.82M	-0.42% -156.03
KMI30	181,199.42 117.76M	-0.38% -696.40
KMIALLSHR	52,088.08 592.55M	-0.27% -143.41
BKTi	29,808.04 22.21M	-0.83% -249.97
OGTi	27,075.99 4.68M	-0.75% -203.95

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	105,060.00	105,945.00 101,390.00	2845.00 2.78%
BRENT CRUDE	66.65	66.67 64.80	1.31 2.00%
RICHARDS BAY COAL MONTHLY	90.00	90.75 90.00	0.00 0.00%
ROTTERDAM COAL MONTHLY	101.80	102.40 101.00	1.25 1.24%
USD RBD PALM OLEIN	998.50	998.50 998.50	0.00 0.00%
CRUDE OIL - WTI	64.77	64.80 62.82	1.40 2.21%
SUGAR #11 WORLD	16.51	16.59 16.32	-0.06 -0.36%